Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Advances in Chronic Kidney Disease
|
February 24, 2009
Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications
Iain C Macdougall, Michael Ashenden
Sports Medicine (Auckland, N.Z.)
|
February 28, 2004
Doping with artificial oxygen carriers: an update
Yorck Olaf Schumacher, Michael Ashenden
Haematologica
|
November 11, 2003
Proof of homologous blood transfusion through quantification of blood group antigens
Margaret Nelson, Hazel Popp, Ken Sharpe, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 15, 2012
Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma
Michael Ashenden, Ken Sharpe, Andrew Garnham, et al.
Haematologica
|
July 28, 2006
The effects of microdose recombinant human erythropoietin regimens in athletes
Michael Ashenden, Emmanuelle Varlet-Marie, Françoise Lasne, et al.
Journal of Clinical Pathology
|
November 1, 2012
Improved alignment of reticulocyte counts between Sysmex XT-2000i instruments
Michael Ashenden, Ken Sharpe, James Habel, et al.
Clinical Chemistry
|
November 25, 2003
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: screening by electrophoresis
Françoise Lasne, Nathalie Crepin, Michael Ashenden, et al.
European Journal of Applied Physiology
|
February 22, 2011
Current markers of the Athlete Blood Passport do not flag microdose EPO doping
Michael Ashenden, Clare E Gough, Andrew Garnham, et al.
Journal of Clinical Pathology
|
November 4, 2011
Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport
Michael Ashenden, Anthea Clarke, Ken Sharpe, et al.
Clinical Chemistry
|
February 7, 2004
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: confirmation by size-exclusion HPLC
Emmanuelle Varlet-Marie, Michael Ashenden, Françoise Lasne, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Advances in Chronic Kidney Disease
|
February 24, 2009
Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications
Iain C Macdougall, Michael Ashenden
Sports Medicine (Auckland, N.Z.)
|
February 28, 2004
Doping with artificial oxygen carriers: an update
Yorck Olaf Schumacher, Michael Ashenden
Haematologica
|
November 11, 2003
Proof of homologous blood transfusion through quantification of blood group antigens
Margaret Nelson, Hazel Popp, Ken Sharpe, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 15, 2012
Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma
Michael Ashenden, Ken Sharpe, Andrew Garnham, et al.
Haematologica
|
July 28, 2006
The effects of microdose recombinant human erythropoietin regimens in athletes
Michael Ashenden, Emmanuelle Varlet-Marie, Françoise Lasne, et al.
Journal of Clinical Pathology
|
November 1, 2012
Improved alignment of reticulocyte counts between Sysmex XT-2000i instruments
Michael Ashenden, Ken Sharpe, James Habel, et al.
Clinical Chemistry
|
November 25, 2003
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: screening by electrophoresis
Françoise Lasne, Nathalie Crepin, Michael Ashenden, et al.
European Journal of Applied Physiology
|
February 22, 2011
Current markers of the Athlete Blood Passport do not flag microdose EPO doping
Michael Ashenden, Clare E Gough, Andrew Garnham, et al.
Journal of Clinical Pathology
|
November 4, 2011
Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport
Michael Ashenden, Anthea Clarke, Ken Sharpe, et al.
Clinical Chemistry
|
February 7, 2004
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: confirmation by size-exclusion HPLC
Emmanuelle Varlet-Marie, Michael Ashenden, Françoise Lasne, et al.
Page
of 1